This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tarsus Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Christopher Stivers: Innovator in Tick Eradication
Introduction
Christopher Stivers is an accomplished inventor based in Lynnfield, MA (US). He has made significant contributions to the field of parasitology, particularly in the development of methods to combat tick-borne diseases. His innovative approach aims to protect human health by eradicating ticks that pose a risk of transmitting diseases such as Lyme disease.
Latest Patents
Stivers holds a patent for a method of eradicating ticks that attach to humans using lotilaner formulations. This patent, which is a crucial advancement in public health, discloses methods for delivering one or more systemic doses of a lotilaner anti-parasitic therapeutic agent to human subjects. This innovative solution is designed to prevent the potential transmission of vector-borne diseases, thereby enhancing the safety and well-being of individuals at risk.
Career Highlights
Christopher Stivers is currently associated with Tarsus Pharmaceuticals, Inc., where he continues to work on groundbreaking solutions in the field of parasitology. His expertise and dedication to innovation have positioned him as a key player in the development of effective treatments against tick-borne diseases.
Collaborations
Stivers collaborates with notable professionals in his field, including Bobak Robert Azamian and Douglas Michael Ackermann, Jr. These partnerships enhance the research and development efforts at Tarsus Pharmaceuticals, Inc., fostering an environment of innovation and progress.
Conclusion
Christopher Stivers is a pioneering inventor whose work in tick eradication is making a significant impact on public health. His innovative methods and collaborations are paving the way for advancements in the prevention of tick-borne diseases.